Compound Detail
CHEMBL403977
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL403977 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | MZEUFXJDMMSPCB-UHFFFAOYSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
402.5
MW (Da)
5.24
ALogP
4
HBA
0
HBD
59.9
PSA (Ų)
0.47
QED
1
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 8.57
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 8.57 | 8.57 | 2.7 | 1 |
| Cytochrome P450 2C9 CHEMBL3397 | IC50 | 6.96 | 6.96 | 110.0 | 1 |
| Blood CHEMBL613416 | IC50 | 6.28 | 6.28 | 520.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 2.7 | nM | 8.57 | Inhibition of PDE4 expressed in SF9 cells | 18207397 |
| Cytochrome P450 2C9 | IC50 | = | 110.0 | nM | 6.96 | Inhibition of CYP2C9 | 18207397 |
| Blood | IC50 | = | 520.0 | nM | 6.28 | Inhibition of LPS-stimulated TNFalpha release in human whole blood | 18207397 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18207397 | 10.1016/j.bmcl.2008.01.004 | Unchecked | 1 |
| 18207397 | 10.1016/j.bmcl.2008.01.004 | Blood | 1 |
| 18207397 | 10.1016/j.bmcl.2008.01.004 | Cytochrome P450 2C9 | 1 |
Data from ChEMBL 36 via Core Engine